National Cancer Institute

National Cancer Institute
Name	National Cancer Institute
Formed	August 5, 1937
Jurisdiction	United States federal government
Headquarters	Bethesda, Maryland
Chief1 position	Director
Parent agency	National Institutes of Health

National Cancer Institute. It is the United States federal government's principal agency for cancer research and training, operating as part of the National Institutes of Health within the U.S. Department of Health and Human Services. Established by the National Cancer Institute Act in 1937, it coordinates the National Cancer Program and conducts a comprehensive effort to reduce the burden of cancer. The institute supports and conducts research across the spectrum from basic laboratory science to clinical trials, while also providing authoritative information to the public and healthcare professionals.

History

The agency was created through the passage of the National Cancer Institute Act, signed into law by President Franklin D. Roosevelt on August 5, 1937. This made it the first of the now numerous institutes comprising the National Institutes of Health. A major expansion of its authority and resources occurred with the National Cancer Act of 1971, often referred to as the "War on Cancer," which was signed by President Richard Nixon and provided increased funding and autonomy. Throughout its history, it has been headquartered at the NIH campus in Bethesda, Maryland, and has played a pivotal role in landmark efforts like the Human Genome Project.

Organization and leadership

The agency is led by a director, who is appointed by the President of the United States and oversees its extensive intramural and extramural research divisions. Key components include the Center for Cancer Research, which conducts basic and clinical intramural science, and the Division of Cancer Epidemiology and Genetics. It operates under the broader umbrella of the National Institutes of Health, with its director reporting to the NIH Director. The organization also benefits from guidance provided by the National Cancer Advisory Board and the President's Cancer Panel.

Research programs and initiatives

Its research portfolio is vast, encompassing initiatives such as the Cancer Moonshot, reignited under the administration of President Joe Biden to accelerate progress. It manages a nationwide network of NCI-Designated Cancer Centers, including prestigious institutions like the Memorial Sloan Kettering Cancer Center and the MD Anderson Cancer Center. Major programs include the Surveillance, Epidemiology, and End Results program for cancer statistics, the The Cancer Genome Atlas for genomic characterization, and the National Clinical Trials Network for coordinating large-scale studies across institutions like the ECOG-ACRIN Cancer Research Group.

Cancer information and public outreach

A critical function is disseminating evidence-based information through services like the Cancer Information Service, a public telephone inquiry line. Its primary online resource for patients and the public is the comprehensive PDQ cancer information database. The institute also maintains extensive resources for healthcare professionals regarding screening, treatment, and supportive care, collaborating with organizations such as the American Cancer Society. Public outreach campaigns often focus on prevention, covering topics like tobacco control and HPV vaccination.

Funding and budget

The agency receives its annual appropriation through the United States Congress, primarily via the Department of Health and Human Services budget. A significant portion of its budget is allocated as grants and contracts to external researchers at universities, hospitals, and research institutes across the country and internationally. Funding supports everything from individual R01 grants to large cooperative agreements and specialized centers. Its budget has historically been influenced by legislative initiatives, most notably the National Cancer Act of 1971 and the recent Cancer Moonshot.

Notable achievements and impact

Its work has been fundamental to numerous breakthroughs in cancer prevention, diagnosis, and treatment. It supported pivotal research leading to the development of chemotherapy drugs, tamoxifen, and preventive HPV vaccines. The institute's long-term studies, such as the Framingham Heart Study and the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial, have shaped public health guidelines. Its efforts in tobacco control research contributed significantly to the landmark Surgeon General's Report on smoking and health. The Surveillance, Epidemiology, and End Results program remains the definitive source for cancer incidence and survival statistics in the United States.

Category:National Institutes of Health Category:Medical and health organizations based in Maryland Category:1937 establishments in the United States